COMMUNIQUÉS West-GlobeNewswire

IntelGenx Announces Resubmission of RIZAPORT® New Drug Application
26/09/2019
SAINT LAURENT, Quebec, Sept. 26, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has resubmitted its 505(b)(2) [...]
Inspire Medical Systems, Inc. Announces Additional Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy
26/09/2019
National Government Services and CGS Administrators, collectively representing 12 states, issue draft policies initiating open public comment period MINNEAPOLIS, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Inspire Medical [...]
Retrophin to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the 2019 Cantor Global Healthcare Conference in New York City [...]
Arbitration Decision Affirms Intellia Therapeutics’ Interpretation of Licensing Agreement with Caribou Biosciences on the CRISPR/Cas9 Technology
26/09/2019
Interim Award concluded all technology in dispute was exclusively licensed to Intellia Parties must negotiate terms and payments to Intellia for Caribou’s use of the chemically modified guide RNAs CAMBRIDGE, Mass., Sept [...]
CorMedix Inc. to Present at the Cantor 2019 Global Healthcare Conference
26/09/2019
BERKELEY HEIGHTS, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting
26/09/2019
BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that all proposals related to its proposed merger with Ocugen, Inc. (“Ocugen”) were [...]
Geron to Present at 2019 Cantor Global Healthcare Conference
26/09/2019
MENLO PARK, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at [...]
Allies for Every Child joins forces with RaiseAChild and UCLA TIES for Families creating The Community Collaborative, a network with a shared purpose of reimagining the experience of children and families within the foster care community
26/09/2019
LOS ANGELES, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Allies for Every Child, along with RaiseAChild and UCLA TIES for Families, are excited to announce they are the founding members of The Community Collaborative, a network [...]
T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
LEXINGTON, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that John [...]
GENFIT Reinforces Corporate Leadership in the U.S.
26/09/2019
GENFIT Reinforces Corporate Leadership in the U.S. Lille (France), Cambridge (Massachusetts, United States), September 26, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to [...]
GENFIT renforce son équipe dirigeante aux États-Unis
26/09/2019
GENFIT renforce son équipe dirigeante aux États-Unis Lille (France), Cambridge (Massachusetts, États-Unis), le 26 septembre 2019 – GENFIT (Nasdaq et Euronext : GNFT) , société biopharmaceutique de phase avancée [...]
Kaleido Biosciences Announces CFO Transition
26/09/2019
LEXINGTON, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and [...]
Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering
26/09/2019
AUSTIN, Texas, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 3,000, [...]
Minerva Neurosciences to Host Conference Call and Live Webcast on Tuesday, October 1 at 8:30 AM ET
26/09/2019
WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets
26/09/2019
Includes royalty interest in NIR178 EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired a royalty interest in six clinical-stage assets targeting the [...]
Otonomy to Present at the Cantor Global Healthcare Conference
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]
Menlo Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
REDWOOD CITY, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Evelo Biosciences to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
CAMBRIDGE, Mass,, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, today announced that [...]
MyoKardia to Present at 2019 Cantor Global Healthcare Conference
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will participate in a fireside chat at the 2019 Cantor Global [...]

Pages